Today in Science
SEE OTHER BRANDS

Fresh science news from the world

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on April 2, 2025

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies Focus on developing commercial opportunities, spin-outs, joint- …

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

GigaCloud Technology Inc Increases Share Repurchase Program by $16 Million

GigaCloud Technology Inc Increases Share Repurchase Program by $16 Million

EL MONTE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that on March 28, …

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the …

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. FibroGen’s management team will be …

GRI Bio Announces Closing of $5.0 Million Public Offering

GRI Bio Announces Closing of $5.0 Million Public Offering

LA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial …

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential …

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious …

BioCryst to Present at Upcoming Investor Conference

BioCryst to Present at Upcoming Investor Conference

RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 9:30 a …

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

Bierman Autism Centers Partners with ASAT to Launch Limited-Edition Autism Awareness T-Shirt

Bierman Autism Centers Partners with ASAT to Launch Limited-Edition Autism Awareness T-Shirt

Proceeds to Support Evidence-Based Autism Treatment and Education INDIANAPOLIS, IN, UNITED STATES, April 2, 2025 /⁨EINPresswire.com⁩/ -- Bierman Autism Centers (BAC) is proud to announce its partnership with the Association for Science in Autism Treatment …

Marketstrat launches Markintel™ Methodology & Frameworks for Actionable Insights in MedTech & Healthcare

Marketstrat launches Markintel™ Methodology & Frameworks for Actionable Insights in MedTech & Healthcare

Markintel™ suite delivers evolving market intelligence for data-driven sectors, bridging insight gaps with actionable frameworks …

Anywhere365 drives the transformation of customer experience with AI, and unveils new identity: AnywhereNow

Anywhere365 drives the transformation of customer experience with AI, and unveils new identity: AnywhereNow

Perth, Australia 3 April 2025 - Anywhere365, a global pioneer in transforming customer experience with AI solutions, has unveiled its new brand identity, AnywhereNow. Building on the company’s history, the new brand steps up into a faster paced identity, …

From pledges to action: the global struggle for carbon neutrality

From pledges to action: the global struggle for carbon neutrality

FAYETTEVILLE, GA, UNITED STATES, April 2, 2025 /⁨EINPresswire.com⁩/ -- The global race toward carbon neutrality has gained momentum, yet the gap between promises and execution remains stark. A groundbreaking study assessing 197 countries finds that while …

Sunlight to power: innovative interface engineering for high-performance perovskite solar cells

Sunlight to power: innovative interface engineering for high-performance perovskite solar cells

A novel study has unveiled a transformative advancement in perovskite solar cells through bilayer interface engineering. FAYETTEVILLE, GA, UNITED STATES, April 2, 2025 /⁨EINPresswire.com⁩/ -- A novel study has unveiled a transformative advancement in …

Nioko Resources Files Early Warning Report in Respect of Orezone Gold Corporation

Nioko Resources Files Early Warning Report in Respect of Orezone Gold Corporation

OUAGADOUGOU, Burkina Faso, April 02, 2025 (GLOBE NEWSWIRE) -- This news release is issued by Nioko Resources Corporation (“Nioko Resources” or the “Acquiror”) pursuant to the early warning requirements of Canada’s National Instrument 62-104 and National …

El mercado del bienestar crece: Lyrah apuesta por una nueva forma de sentir

El mercado del bienestar crece: Lyrah apuesta por una nueva forma de sentir

Con el mercado wellness proyectado a $8.5B para 2027, Lyrah propone una alternativa sensorial desde México para transformar el bienestar emocional. MEXICO, April 2, 2025 /⁨EINPresswire.com⁩/ -- El bienestar emocional ha dejado de ser una tendencia para …

Orezone Gold Announces Closing of Private Placement with Nioko

Orezone Gold Announces Closing of Private Placement with Nioko

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) announces that further to …

Enamine and ChemPass Collaborate to Accelerate Hit Discovery

Enamine and ChemPass Collaborate to Accelerate Hit Discovery

KYIV, UKRAINE, April 2, 2025 /⁨EINPresswire.com⁩/ -- Enamine, the leading provider of chemical compounds and drug discovery services, and ChemPass, a contract research organization for computational and AI-assisted software, today announced their start of …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service